Impact of CES1A2 A(-816)C polymorphism on platelet reactivity after clopidogrel treatment in Chinese patients with coronary heart disease
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: MIAO, Liyan (Suzhou, China)
- Co-author(s): Ding, X.L. (The First Affiliated Hospital of Soochow University, Suzhou, China)
Jiang, B. (The First Affiliated Hospital of Soochow University, Suzhou, China)
Xie, C. (The First Affiliated Hospital of Soochow University, Suzhou, China)
Background: Despite dual antiplatelet therapy, major adverse cardiovascular event remains a devastating and unpredictable complication of percutaneous coronary intervention...
Aims: The aim of this study was to assess the association between CES1A2, PON1, CYP2C19, ABCB1 genetic variants and antiplatelet reactivity of clopidogrel in Chinese patients The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.